Back to Search
MATTHEW DUDLEY, MD
MD
Anesthesiology Physician
NPI: 1548525611IndividualAccepts Medicare
Specialties, Licenses & Credentials
Paramedic
Emergency Medical Technician, Paramedic
Code: 146L00000X
3201001683(MI)
Critical Care Medicine (Anesthesiology) Physician
Anesthesiology — Critical Care Medicine
Code: 207LC0200X
A131338(CA)
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
A131338(CA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 2012
Research & Publications (20)
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
PMID 18809613·J Clin Oncol·2008
3-trial
Kinetics of a chlorate-accumulating, perchlorate-reducing bacterium.
PMID 18281075·Water Res·2008
8-other
Aerosol antibiotics: considerations in pharmacological and clinical evaluation.
PMID 19036576·Curr Opin Biotechnol·2008
6-review
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
PMID 15800326·J Clin Oncol·2005
3-trial
Adoptive-cell-transfer therapy for the treatment of patients with cancer.
PMID 12951585·Nat Rev Cancer·2003
6-review
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
PMID 12242449·Science·2002
3-trial
Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.
PMID 11050452·Curr Opin Microbiol·2000
6-review
Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy.
PMID 19389403·J Immunol Methods·2009
8-other
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
PMID 19423728·Blood·2009
8-other
Adoptive cell therapy for the treatment of patients with metastatic melanoma.
PMID 19304471·Curr Opin Immunol·2009
6-review
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
PMID 19451549·Blood·2009
3-trial
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma.
PMID 19410956·Ophthalmology·2009
5-case
Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.
PMID 19528273·Antimicrob Agents Chemother·2009
7-preclinical
Research priorities in suicide prevention in Australia. A comparison of current research efforts and stakeholder-identified priorities.
PMID 19069610·Crisis·2008
6-review
New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?
PMID 18465372·Aust N Z J Psychiatry·2008
6-review
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy.
PMID 18779745·J Immunother·2008
8-other
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.
PMID 18444786·Hum Gene Ther·2008
3-trial
Adoptive cell transfer: a clinical path to effective cancer immunotherapy.
PMID 18354418·Nat Rev Cancer·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 505 PARNASSUS AVE STE M917
SAN FRANCISCO, CA 94143 - Phone
- (415) 514-3781
Quick Facts
- NPI
- 1548525611
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile